Transcenta Holding

Chemicals & Related Products · New Jersey, United States · 201-500 Employees

View Company Info for Free

Overview

Headquarters

3 Independence Way Ste 114, Princeton, N...

Phone Number

+86 57128279502

Revenue

$28.2 Million

Industry

Chemicals & Related Products Manufacturing Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1

About Transcenta Holding

Transcenta Holding is a global fully integrated biotherapeutics company that specializes in developing innovative biologics, including antibodies targeting Claudin 18.2. The company employs cutting-edge technology to create differentiated and affordable treatments for patients, with a focus on oncology. With a robust pipeline of products, including Osemitamab (TST001), TST002, and TST003, Transcenta is committed to advancing clinical development and manufacturing processes. Their strategic partnerships with leading pharmaceutical companies enhance their capabilities in research and development, ensuring a strong presence in the biopharmaceutical industry.Explore more
Transcenta Holding's Social MediaPopular SearchesTranscenta Holding LtdTranscentaTranscenta HoldingTranscenta TherapeuticsSIC Code 28,283NAICS Code 32,325Show more

Transcenta Holding Org Chart

PhoneEmail
CG
United States flag for contact location.

Executive Vice President & Global Chief Medic...

PhoneEmail
WL
United States flag for contact location.

Acting Chief Financial Officer & Senior VP, B...

PhoneEmail
CQ
United States flag for contact location.

Chief Marketing Officer & Head Executive VP, ...

PhoneEmail
DW
United States flag for contact location.

Chief Financial Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.
JS
United States flag for contact location.

Vice President, Clinical Operations

PhoneEmail
ZY
United States flag for contact location.

Vice President and Head of Clinical Pharmacol...

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Transcenta Holding your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Transcenta Holding

Compare insights from companies similar to Transcenta Holding, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Transcenta Holding

$28.2M
201-500
Private
$105M
2019
CG
Caroline GermaExecutive Vice President & Global Chief Medical Officer, Medicine Development
$190.2M
501-1,000
Private
$29M
2007
Liangzhi Xie, President & Chief Executive Officer at Sino Biological
Liangzhi XiePresident & CEO
$112.7M
201-500
Private
$113.6M
2009
Shawn O'Brien, Chief Operating Officer at Abzena
Shawn O'BrienChief Operating Officer
$89.5M
51-200
Public
$177.8M
2016
Jingsong Wang, Founder & Chief Executive Officer at Harbour BioMed
Jingsong WangFounder & CEO
$20.9M
201-500
Private
<$5M
2005
KH
Ken HiltonManager, Operations
$17.3M
51-200
Private
$71M
2014
GR
Guy RachmuthSenior Vice President, Global Head of Strategic BD and Partnerships. Chief Business Officer
$8.6M
201-500
Private
-
2013
JL
June LiaoExecutive VP, Product Development
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Transcenta Holding is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Transcenta Holding is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Transcenta Holding.

Transcenta Holding financials insights

Gather financial insights about Transcenta Holding, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2020

Other Financing Round

$105M

See All Transcenta Holding's Financials Insights

Transcenta Holding Tech Stack

A closer look at the technologies used by Transcenta Holding

Most Recent Scoops

Event
Product Marketing, Events, Business Intelligence, Engineering, Analytics & Insights, Research & Development, Sales, Search, Software, Bioengineering, Laboratory Operations, Clinical Operations, Field Marketing, Operations
Person-Based
Left Company
Executive Move
Executive Moves, Left Company
Open Position
Open Position
See more scoops

Top Chemicals & Related Products Companies

Frequently Asked Questions Regarding Transcenta Holding

What is Transcenta Holding's official website?
Transcenta Holding's official website is www.transcenta.com
What is Transcenta Holding's Revenue?
Transcenta Holding's revenue is $28.2 Million
What is Transcenta Holding's SIC code?
Transcenta Holding's SIC: 28,283
What is Transcenta Holding's NAICS code?
Transcenta Holding's NAICS: 32,325
How many employees does Transcenta Holding have?
Transcenta Holding has 201-500 employees
What industry does Transcenta Holding belong to?
Transcenta Holding is in the industry of: Chemicals & Related Products, Manufacturing, Business Services
What is Transcenta Holding competition?
Transcenta Holding top competitors include: Abzena, Sino Biological, United BioPharma, Harbour BioMed
What technology does Transcenta Holding use?
Some of the popular technologies that Transcenta Holding uses are: MATLAB, YouTube, R, Microsoft 365
Who is the CFO of Transcenta Holding?
Transcenta Holding's CFO is Weiwei Liang
How do I contact Transcenta Holding?
Transcenta Holding contact info: Phone number: +86 57128279502 Website: www.transcenta.com
What does Transcenta Holding do?

Transcenta Holding is a global fully integrated biotherapeutics company that specializes in developing innovative biologics, including antibodies targeting Claudin 18.2. The company employs cutting-edge technology to create differentiated and affordable treatments for patients, with a focus on oncology. With a robust pipeline of products, including... Osemitamab (TST001), TST002, and TST003, Transcenta is committed to advancing clinical development and manufacturing processes. Their strategic partnerships with leading pharmaceutical companies enhance their capabilities in research and development, ensuring a strong presence in the biopharmaceutical industry.Read More

What are Transcenta Holding social media links?
Transcenta Holding Linkedin page
Who invested in Transcenta Holding?
Transcenta Holding has 3 investors including Country Garden Venture Capital, China Structural Reform and Qatar Investment.
Is Transcenta Holding a public company?
Transcenta Holding is private company therefore does not currently have an official ticker symbol
See more information about Transcenta Holding

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.